The results of in vitro studies performed with soluble vWF and fibrosarcoma cells indicate that vWF augments cancer cell-induced platelet aggregation by a two-phasic process, in which a close interaction occurs between vWF, platelets and tumor cells, and this is preceded by the adhesion of platelets to vWF [41]. The gene discussed is VWF; the disease is neoplasm.